Growing community of inventors

Leuven, Belgium

Sébastien Dumas

Average Co-Inventor Count = 8.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Sébastien DumasJean-Daniel Brion (1 patent)Sébastien DumasMouad Alami (1 patent)Sébastien DumasSamir Messaoudi (1 patent)Sébastien DumasSylvia Cohen-Kaminsky (1 patent)Sébastien DumasMarc Humbert (1 patent)Sébastien DumasGilles Bru-Mercier (1 patent)Sébastien DumasGilles Galvani (1 patent)Sébastien DumasSamir Messaoudi (2 patents)Sébastien DumasMouad Alami (2 patents)Sébastien DumasJean-Daniel Brion (2 patents)Sébastien DumasSébastien Dumas (1 patent)Jean-Daniel BrionJean-Daniel Brion (15 patents)Mouad AlamiMouad Alami (11 patents)Samir MessaoudiSamir Messaoudi (6 patents)Sylvia Cohen-KaminskySylvia Cohen-Kaminsky (5 patents)Marc HumbertMarc Humbert (5 patents)Gilles Bru-MercierGilles Bru-Mercier (5 patents)Gilles GalvaniGilles Galvani (5 patents)Samir MessaoudiSamir Messaoudi (2 patents)Mouad AlamiMouad Alami (2 patents)Jean-Daniel BrionJean-Daniel Brion (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre National De La Recherche Scientifique (1 from 5,072 patents)

2. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)

3. Assistance Publique-hopitaux De Paris (1 from 317 patents)

4. Université Paris—sud (1 from 99 patents)

5. Inserm (institut National De La Sante Et De La Recherche Medicale) (37 patents)


1 patent:

1. 10538482 - Adamantane and memantine derivatives as peripheral NMDA receptor antagonists

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…